931 results on '"Vanderheyden, Marc"'
Search Results
252. Severity of Coronary Arterial Stenoses Responsible for Acute Coronary Syndromes
253. Chronic Kidney Disease is Associated With Decreased Exercise Capacity and Impaired Ventilatory Efficiency in Heart Transplantation Patients
254. Cardiac Resynchronization Therapy in Dyssynchronous Heart Failure
255. Author's response to “C-reactive protein and severity of coronary allograft vasculopathy.”
256. Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition
257. Nonmyocardial Production of ST2 Protein in Human Hypertrophy and Failure Is Related to Diastolic Load
258. Abstract 3052: Initial Human Experiences with a Non-Stented Coronary Sinus Device for the Treatment of Functional Mitral Regurgitation in Heart Failure Patients
259. Abstract 4470: Long Term Follow Up After Fractional Flow Reserve-guided Treatment Of ‘Moderate’ Left Main Coronary Artery Stenosis
260. Cardiac Dyssynchrony in Congestive Heart Failure and Atrial Fibrillation
261. Reply
262. Coronary aneurysm in Lyme Disease: Treatment by covered stent
263. Relation of Low Response to Clopidogrel Assessed With Point-of-Care Assay to Periprocedural Myonecrosis in Patients Undergoing Elective Coronary Stenting for Stable Angina Pectoris
264. Mesenchymal Stem Cells and Cardiac Repair: Principles and Practice
265. Endomyocardial Upregulation of β1 Adrenoreceptor Gene Expression and Myocardial Contractile Reserve Following Cardiac Resynchronization Therapy
266. Tissue Doppler predicts long-term clinical outcome after cardiac resynchronization therapy
267. Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy
268. Early and late effects of cardiac resynchronization therapy on force–frequency relation and contractility regulating gene expression in heart failure patients
269. Abstract 1603: Factors and Mechanisms Associated with Improved Cardiopulmonary Performance after Cardiac Resynchronization Therapy. An Exercise Echocardiography Study.
270. Abstract 3278: Noninvasive Home Monitoring of Pulmonary Artery Pressure by the RemonCHF Device: First Multicenter Experience
271. GLU-27 variant of β2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease
272. Impact of Intracoronary Cell Therapy on Left Ventricular Function in the Setting of Acute Myocardial Infarction
273. Time-Dependent Effects on Coronary Remodeling and Epicardial Conductance after Intracoronary Injection of Enriched Hematopoietic Bone Marrow Stem Cells in Patients with Previous Myocardial Infarction
274. Severe Left Ventricular Dyssynchrony Is Associated With Poor Prognosis in Patients With Moderate Systolic Heart Failure Undergoing Coronary Artery Bypass Grafting
275. Bringing Cardiac Cell Therapy With Bone Marrow Stem Cells to the Clinic: Where are We now?
276. Response of the Oxygen Uptake Efficiency Slope to Orthotopic Heart Transplantation: Lack of Correlation With Changes in Central Hemodynamic Parameters and Resting Lung Function
277. Effect of mitral valve repair on exercise tolerance in asymptomatic patients with organic mitral regurgitation
278. Thr164Ilepolymorphism of β2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy
279. Response of the oxygen uptake efficiency slope to exercise training in patients with chronic heart failure
280. Role of Imaging in Cardiac Stem Cell Therapy
281. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium
282. The effect of endurance training on exercise capacity following cardiac resynchronization therapy in chronic heart failure patients: a pilot trial
283. Impact of Alpha- and Beta-Adrenergic Receptor Blockers on Fractional Flow Reserve and Index of Microvascular Resistance.
284. Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses.
285. Activation of the Ergoreceptors in Cardiac Patients With and Without Heart Failure.
286. VE/Vco2 slope and oxygen uptake efficiency slope in patients with coronary artery disease and intermediate peakVo2
287. Prospective evaluation of the oxygen uptake efficiency slope as a submaximal predictor of peak oxygen uptake in aged patients with ischemic heart disease
288. Cardiac Resynchronization Therapy Delays Heart Transplantation in Patients With End-stage Heart Failure and Mechanical Dyssynchrony
289. Intracoronary Delivery of Hematopoietic Bone Marrow Stem Cells and Luminal Loss of the Infarct-Related Artery in Patients With Recent Myocardial Infarction
290. Dipeptidyl-Peptidase IV Converts Intact B-Type Natriuretic Peptide into Its des-SerPro Form
291. Novel Device-Based Strategies in Treatment of Chronic Heart Failure.
292. Hyperdynamic Myocardial Response to Beta-Adrenergic Stimulation in Patients With Chest Pain and Normal Coronary Arteries
293. Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction
294. Secondary cardiac tumour originating from laryngeal carcinoma
295. Polymorphic Ventricular Tachycardia Induced by Left Ventricular Pacing
296. Hemodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failure
297. Improvement of Left Ventricular Function After Cardiac Resynchronization Therapy Is Predicted by Tissue Doppler Imaging Echocardiography
298. Brain and other natriuretic peptides: molecular aspects
299. Ischemic Cardiomyopathy:Value of Different MRI Techniques for Prediction of Functional Recovery After Revascularization
300. Biologic ex-vivopre differentiation of adult bone marrow-derived mesenchymal stem cells for cardiac repair in a chronic dog model of myocardial infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.